| Leslie Mccasland, MD | |
|
2231 Hill Park Cove, Jonesboro, AR 72401 | |
| (870) 333-2721 | |
| (870) 333-2720 |
| Full Name | Leslie Mccasland |
|---|---|
| Gender | Female |
| Speciality | Rheumatology |
| Experience | 30 Years |
| Location | 2231 Hill Park Cove, Jonesboro, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003873019 | NPI | - | NPPES |
| 134967001 | Medicaid | AR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | E-1651 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Memorial Hospital Jonesboro, Inc. | Jonesboro, AR | Hospital |
| St Bernards Medical Center | Jonesboro, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arthritis And Rheumatism Associates Llc | 2769765015 | 2 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation, Journal of the American Heart Association.
The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.
The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.
› Verified 7 days ago
| Entity Name | Northeast Arkansas Clinic Charitable Foundation, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861721839 PECOS PAC ID: 2961547526 Enrollment ID: O20100315000190 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation, Journal of the American Heart Association.
The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.
The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.
› Verified 7 days ago
| Entity Name | Arthritis And Rheumatism Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396280780 PECOS PAC ID: 2769765015 Enrollment ID: O20170210000828 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation, Journal of the American Heart Association.
The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.
The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Leslie Mccasland, MD 2231 Hill Park Cove, Jonesboro, AR 72401 Ph: (870) 333-2721 | Leslie Mccasland, MD 2231 Hill Park Cove, Jonesboro, AR 72401 Ph: (870) 333-2721 |
News Archive
Genticel, a French biotechnology company and developer of innovative immunotherapies to prevent cancers caused by the human papillomavirus (HPV), announces today positive preclinical in vivo proof of concept results of GTL002, its multivalent HPV therapeutic vaccine candidate based on the Company's versatile Vaxiclase platform.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
Female heart attack patients undergoing angioplasty have a higher risk of death than men, but stenting may improve their outcomes, according to a study reported in Circulation, Journal of the American Heart Association.
The antiepileptic drug ezogabine reduced pathologic excitability of cortical and spinal motor neuron cells that are early signs of clinical dysfunction in people with amyotrophic lateral sclerosis (ALS), according to a study conducted by the Neurological Clinical Research Institute of Massachusetts General Hospital.
The National Institute of Neurological Disorders and Stroke has awarded two UTHSC researchers over $1.9 million to study the pathogenesis of white matter damage, a main contributing factor to dementia.
› Verified 7 days ago
Dr. Naveed Younis, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 201 E Oak Ave, Jonesboro, AR 72401 Phone: 870-935-6729 | |
Veryl D Hodges, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198 Fax: 870-910-7700 | |
Veronica Easton, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 300 Carson St, Jonesboro, AR 72401 Phone: 870-932-1198 | |
William B Roth, DO Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 4800 E Johnson Ave, Jonesboro, AR 72405 Phone: 870-936-1000 Fax: 870-936-2038 | |
Dr. Roger Hill, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 201 E Oak Ave., Jonesboro, AR 72401 Phone: 870-935-6729 Fax: 870-268-4410 | |
Michael D. Hightower, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 311 Matthews Ave, Jonesboro, AR 72401 Phone: 870-935-4150 Fax: 870-934-5368 |